Imaging Wire #300
“What sounds like sci-fi is now becoming a reality.” UK NHS chief executive, Sir Simon Stevens, on diagnostic “pill cameras” becoming a reality. Imaging Wire Sponsors…
Making an OEM
“We will become the largest global player in secondary screening and diagnostics for women with dense breasts. . .” SmartBreast CEO, Dr. James Hugg, on his…
Very Different AI Pathways | Another Extender Debate
“This isn’t about patient safety, this is just protectionism.” One radiographer’s response to the Royal Australian and New Zealand College of Radiologists’ position against radiographers “seeking…
FDA Siege | Debiased AI | Inpatient Screening
“We cannot allow unregulated AI to make clinical decisions.” Hardian Health’s Dr. Hugh Harvey in response to the FDA’s move to waive regulatory approval requirements for…
No AI Resistance
“This is not going to be a resistance kind of thing . . .” Stanford’s Matthew Lungren, MD MPH on radiologists’ growing embrace of AI (definitely…
AI Faceoff | COVID in the CT | Radres Handhelds
“A little knowledge, so the saying goes, can be a dangerous thing.” Signify Research’s Alan Stoddart on the potential pitfalls of ultrasound simplification and home adoption.…
Big Get Bigger | PoC MRI Works | Rogue LCS
“This is a milestone day.” Radiology Partners CEO, Rich Whitney, on the significance of RP’s acquisition of Mednax Radiology Solutions. Happy 250th Imaging Wire issue, everyone.…
AI Promises and Pitfalls | COVID Impact
“Accountants have known this for years. They use calculators, which you could think of is as a simplistic form of AI, to help them remedy their…
Mammography Evidence | Rads Ready to Reopen
“. . . the irony is that they get more money because they’re more dishonest,” Harvard professor, Malcolm Sparrow, on how some of the leading COVID-19…
Empathy Test | Perspectives on Transparency | Mammography Slowdown
“I have no idea what any of this ‘transparency’ will actually accomplish. My hope is that it will help to enlighten the fact that private pay…
